We initially tested the impact of the nonspecific RAGE/HMGB1 signaling inhibitor ethyl pyruvate on host survival following a uniformly lethal infection with SARS-CoV-2 (1 × 104 TCID50) (35). This evidence concerns the gene HMGB1 and infection.